TIRRO', ELENA
 Distribuzione geografica
Continente #
NA - Nord America 405
EU - Europa 300
AF - Africa 97
AS - Asia 86
OC - Oceania 1
SA - Sud America 1
Totale 890
Nazione #
US - Stati Uniti d'America 398
IT - Italia 112
IE - Irlanda 73
CI - Costa d'Avorio 62
CN - Cina 38
SN - Senegal 35
DE - Germania 33
VN - Vietnam 26
RU - Federazione Russa 18
BE - Belgio 13
UA - Ucraina 11
SE - Svezia 8
CA - Canada 7
GB - Regno Unito 7
UZ - Uzbekistan 5
FR - Francia 4
IN - India 4
PL - Polonia 4
CH - Svizzera 3
NL - Olanda 3
NO - Norvegia 3
SG - Singapore 3
TR - Turchia 3
GR - Grecia 2
HK - Hong Kong 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
ES - Italia 1
LB - Libano 1
LU - Lussemburgo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 890
Città #
Chandler 151
Dublin 73
Abidjan 62
Catania 37
Dakar 35
Grafing 23
Cambridge 22
Ashburn 21
Andover 20
Dong Ket 20
Lawrence 20
Wilmington 15
Brussels 13
Des Moines 13
Nanjing 11
Jacksonville 8
Beijing 7
Jiaxing 7
Hanoi 6
Los Angeles 5
Falls Church 4
Giardini-Naxos 4
Houston 4
Pune 4
Toronto 4
Boardman 3
Bremen 3
Catanzaro 3
Edinburgh 3
Hanover 3
Oslo 3
Ottawa 3
Saint Petersburg 3
Frankfurt am Main 2
Mascali 2
Palermo 2
Seattle 2
Siracusa 2
Tokyo 2
Woodbridge 2
Zhengzhou 2
Amsterdam 1
Ann Arbor 1
Augusta 1
Bangkok 1
Belgrade 1
Bratislava 1
Changsha 1
Chicago 1
Den Haag 1
Dubai 1
Groningen 1
Hebei 1
Jinan 1
Kocaeli 1
Luxembourg 1
Madrid 1
Manchester 1
Melbourne 1
Messina 1
Milan 1
Moscow 1
Nanchang 1
New York 1
Ozieri 1
Piraino 1
Polska 1
Quintano 1
Redmond 1
Redwood City 1
San Mateo 1
Santa Clara 1
Singapore 1
Sofia 1
Spezzano Della Sila 1
São Paulo 1
Tianjin 1
Villamagna 1
Totale 666
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 83
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 58
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 57
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 51
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 51
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 51
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 51
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 51
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 50
Uncommon long-term survival in a patient with chronic myeloid leukemia 48
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 46
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 45
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 44
New insights in thyroid cancer and p53 family proteins 43
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 42
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 41
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 38
Detection and clinical implications of a novel BCR-ABL1 E12A2 insertion/deletion in a CML patient expressing the E13A2 isoform 37
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 33
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 32
Totale 952
Categoria #
all - tutte 3.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 2 3
2019/2020125 24 2 11 10 12 8 4 12 2 6 10 24
2020/2021124 16 1 5 10 27 6 1 1 26 1 5 25
2021/2022142 2 30 1 2 31 2 22 2 8 0 7 35
2022/2023399 23 39 10 55 19 58 0 93 78 3 17 4
2023/2024137 6 40 4 0 5 63 0 12 0 6 1 0
Totale 952